Literature DB >> 15751556

Clarification of article on Clostridium difficile--associated colitis.

Kenneth Brown.   

Abstract

Entities:  

Mesh：

Year:  2005        PMID： 15751556      PMCID： PMC1472981     

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN： 0008-350X            Impact factor:   3.275


× No keyword cloud information.
  16 in total

1.  Clostridium difficile-associated diarrhea: epidemiology, risk factors, and infection control.

Authors:  K K Lai; Z S Melvin; M J Menard; H R Kotilainen; S Baker
Journal:  Infect Control Hosp Epidemiol       Date:  1997-09       Impact factor: 3.254

Review 2.  Guidelines for the diagnosis and management of Clostridium difficile-associated diarrhea and colitis. American College of Gastroenterology, Practice Parameters Committee.

Authors:  R Fekety
Journal:  Am J Gastroenterol       Date:  1997-05       Impact factor: 10.864

3.  Epidemic Clostridium difficile-associated diarrhea: role of second- and third-generation cephalosporins.

Authors:  D E Nelson; S B Auerbach; A L Baltch; E Desjardin; C Beck-Sague; C Rheal; R P Smith; W R Jarvis
Journal:  Infect Control Hosp Epidemiol       Date:  1994-02       Impact factor: 3.254

4.  Control of nosocomial transmission of Clostridium difficile based on sporadic case surveillance.

Authors:  M J Struelens; A Maas; C Nonhoff; A Deplano; F Rost; E Serruys; M Delmee
Journal:  Am J Med       Date:  1991-09-16       Impact factor: 4.965

5.  Proton pump inhibitors as a risk factor for Clostridium difficile diarrhoea.

Authors:  R Cunningham; B Dale; B Undy; N Gaunt
Journal:  J Hosp Infect       Date:  2003-07       Impact factor: 3.926

6.  Binding of Clostridium difficile cytotoxin and vancomycin by anion-exchange resins.

Authors:  N S Taylor; J G Bartlett
Journal:  J Infect Dis       Date:  1980-01       Impact factor: 5.226

7.  Risk of Clostridium difficile diarrhea among hospital inpatients prescribed proton pump inhibitors: cohort and case-control studies.

Authors:  Sandra Dial; Khalid Alrasadi; Chantal Manoukian; Allen Huang; Dick Menzies
Journal:  CMAJ       Date:  2004-07-06       Impact factor: 8.262

8.  Multiple relapses of Clostridium difficile-associated diarrhea in a cancer patient. Successful control with long-term cholestyramine therapy.

Authors:  M D Moncino; J M Falletta
Journal:  Am J Pediatr Hematol Oncol       Date:  1992-11

9.  Recurrent Clostridium difficile-associated colitis responding to cholestyramine.

Authors:  D Kunimoto; A B Thomson
Journal:  Digestion       Date:  1986       Impact factor: 3.216

10.  Acquisition of Clostridium difficile from the hospital environment.

Authors:  G W Kaatz; S D Gitlin; D R Schaberg; K H Wilson; C A Kauffman; S M Seo; R Fekety
Journal:  Am J Epidemiol       Date:  1988-06       Impact factor: 4.897
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.